newsfilter
← Latest News
PR Newswire·

Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma

SAN DIEGO, May 12, 2022 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), applicable to Halozyme's